Is a complete TMDX research report available?

No complete published report is available for TransMedics Group, Inc. (TMDX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · USD

$66.7

-2.98 (-4.3%)· Recorded snapshot

Market cap	2.3B
Revenue (ttm)	668.5M
Net income (ttm)	151.7M
EPS (ttm)	$4.01
Shares out	34.7M
P/E (trailing)	16.6x
P/E (forward)	37.1x
Volume	946,184
Beta	1.93

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001756262
Company name	TransMedics Group, Inc.
Country	United States
Country code	US
CUSIP number	89377M109
Earnings date	2026-11-05
Earnings time	amc
Employees	898
Employees change	170
Employees growth	23.35%
Enterprise value	$2.7B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2019-05-02
Is primary listing	Yes
Is SPAC	No
ISIN number	US89377M1099
Last 10-K release date	2026-02-24
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.3B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$66.75
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	TMDX
U.S. state	Massachusetts
Website	https://www.transmedics.com

Metric

Value

Amount currency

USD

CIK code

0001756262

Company name

TransMedics Group, Inc.

Country

United States

Country code

CUSIP number

89377M109

Earnings date

2026-11-05

Earnings time

amc

Employees

898

Employees change

170

Employees growth

23.35%

Enterprise value

$2.7B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1998

In index

RUSSELL2000

Industry

Medical Devices

IPO date

2019-05-02

Is primary listing

Yes

Is SPAC

ISIN number

US89377M1099

Last 10-K release date

2026-02-24

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$2.3B

Market cap category

Mid-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$66.75

Price currency

USD

Sector

Healthcare

SIC code

3845

Stock price date

2026-10-28

Symbol

TMDX

U.S. state

Massachusetts

Website

https://www.transmedics.com

Metric	Value
Adjusted P/E ratio	34.64x
Average P/E ratio (3Y)	231.24x
Earnings yield	6.01%
EV/Earnings	18.56x
EV/EBIT	34.5x
EV/EBITDA	24.35x
EV/FCF	35.61x
EV/Sales	4.21x
FCF / EV yield	2.81%
FCF yield	3.27%
Forward EV/Sales	3.49x
Forward P/E	37.1x
Forward P/S	3x
Graham number	36.75951
Graham upside	-47.33%
Industry forward P/E	19.74x
Industry P/E	39.16x
P/(FCF - SBC) ratio	57.68x
P/(OCF - SBC) ratio	22.23x
P/B ratio	4.66x
P/E ratio	16.63x
P/FCF ratio	30.62x
P/OCF ratio	16.58x
P/S ratio	3.62x
PEG ratio	0.77x
Price / tangible book value	4.78x
Price/EBITDA ratio	20.93x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

34.64x

Average P/E ratio (3Y)

231.24x

Earnings yield

6.01%

EV/Earnings

18.56x

EV/EBIT

34.5x

EV/EBITDA

24.35x

EV/FCF

35.61x

EV/Sales

4.21x

FCF / EV yield

2.81%

FCF yield

3.27%

Forward EV/Sales

3.49x

Forward P/E

37.1x

Forward P/S

Graham number

36.75951

Graham upside

-47.33%

Industry forward P/E

19.74x

Industry P/E

39.16x

P/(FCF - SBC) ratio

57.68x

P/(OCF - SBC) ratio

22.23x

P/B ratio

4.66x

P/E ratio

16.63x

P/FCF ratio

30.62x

P/OCF ratio

16.58x

P/S ratio

3.62x

PEG ratio

0.77x

Price / tangible book value

4.78x

Price/EBITDA ratio

20.93x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	12.21%
EBITDA margin	17.3%
FCF margin	11.82%
Gross margin	58.69%
Operating margin	12.21%
Pretax margin	10.85%
Profit margin	22.69%
Profit per employee	$168,930
Profitable quarters	11
Profitable years	2
Revenue per employee	$744,396
ROA	4.33%
ROA (5Y)	-3.31%
ROCE	5.97%
ROE	36.28%
ROE (5Y)	-4.34%
ROIC	9.02%
ROIC (5Y)	-59.58%
SBC / revenue	5.55%
Tax / revenue	-11.84%

Metric

Value

EBIT margin

12.21%

EBITDA margin

17.3%

FCF margin

11.82%

Gross margin

58.69%

Operating margin

12.21%

Pretax margin

10.85%

Profit margin

22.69%

Profit per employee

$168,930

Profitable quarters

Profitable years

Revenue per employee

$744,396

ROA

4.33%

ROA (5Y)

-3.31%

ROCE

5.97%

ROE

36.28%

ROE (5Y)

-4.34%

ROIC

9.02%

ROIC (5Y)

-59.58%

SBC / revenue

5.55%

Tax / revenue

-11.84%

Metric	Value
EPS growth	98.94%
EPS growth (Q)	-55.84%
EPS growth (QoQ)	102.87%
EPS growth years	4
FCF growth	355.52%
FCF growth (Q)	-87.62%
Gross profit growth	23.51%
Gross profit growth (Q)	17.2%
Gross profit growth 3Y	55.51%
Gross profit growth 5Y	80.88%
Net income growth	111.69%
Net income growth (Q)	-57.94%
Net income growth (QoQ)	100.71%
Net income growth years	4
OCF growth	26.59%
OCF growth (Q)	-81.11%
OCF growth (QoQ)	-29.45%
Operating income growth	6.57%
Operating income growth (Q)	-35.09%
Revenue growth	25.82%
Revenue growth (Q)	20.7%
Revenue growth (QoQ)	9.21%
Revenue growth 3Y	64.17%
Revenue growth 5Y	86.11%
Revenue growth quarters	19
Revenue growth years	9

Metric

Value

EPS growth

98.94%

EPS growth (Q)

-55.84%

EPS growth (QoQ)

102.87%

EPS growth years

FCF growth

355.52%

FCF growth (Q)

-87.62%

Gross profit growth

23.51%

Gross profit growth (Q)

17.2%

Gross profit growth 3Y

55.51%

Gross profit growth 5Y

80.88%

Net income growth

111.69%

Net income growth (Q)

-57.94%

Net income growth (QoQ)

100.71%

Net income growth years

OCF growth

26.59%

OCF growth (Q)

-81.11%

OCF growth (QoQ)

-29.45%

Operating income growth

6.57%

Operating income growth (Q)

-35.09%

Revenue growth

25.82%

Revenue growth (Q)

20.7%

Revenue growth (QoQ)

9.21%

Revenue growth 3Y

64.17%

Revenue growth 5Y

86.11%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-66.9M
Depreciation and amortization	$34M
EBIT	$81.6M
EBITDA	$115.6M
EPS	$4.01
FCF per share	$2.28
Financing cash flow	$11.5M
Free cash flow	$79M
Free cash flow minus SBC	$42M
Gross profit	$392.3M
Income taxes	$-79.1M
Investing cash flow	$-66.9M
Net cash flow	$90M
Net income	$151.7M
Operating cash flow minus SBC	$108.8M
Operating income	$81.6M
Revenue	$668.5M
Stock-based compensation	$37.1M

Metric

Value

Capital expenditures

$-66.9M

Depreciation and amortization

$34M

EBIT

$81.6M

EBITDA

$115.6M

EPS

$4.01

FCF per share

$2.28

Financing cash flow

$11.5M

Free cash flow

$79M

Free cash flow minus SBC

$42M

Gross profit

$392.3M

Income taxes

$-79.1M

Investing cash flow

$-66.9M

Net cash flow

$90M

Net income

$151.7M

Operating cash flow minus SBC

$108.8M

Operating income

$81.6M

Revenue

$668.5M

Stock-based compensation

$37.1M

Metric	Value
Altman Z-Score	3.33
Book value per share	$14.96
Debt / EBITDA	6.99
Debt / equity	1.67
Debt / FCF	10.98
Goodwill	$11.5M
Interest coverage	3.84
Long-term assets	$813.3M
Long-term liabilities	$848.1M
Net cash (debt)	$-395M
Net cash / market cap	-16.32%
Net debt / EBITDA	3.42
Net debt / equity	0.76
Net debt / FCF	5
Piotroski F-Score	4
Property, plant and equipment	$702.4M
Shareholders' equity	$518.1M
Tangible book value	$506.5M
Tangible book value per share	$14.63
Total assets	$1.5B
Total cash	$472.7M
Total debt	$867.7M
Total liabilities	$946.3M
WACC	11.44%

Metric

Value

Altman Z-Score

3.33

Book value per share

$14.96

Debt / EBITDA

6.99

Debt / equity

1.67

Debt / FCF

10.98

Goodwill

$11.5M

Interest coverage

3.84

Long-term assets

$813.3M

Long-term liabilities

$848.1M

Net cash (debt)

$-395M

Net cash / market cap

-16.32%

Net debt / EBITDA

3.42

Net debt / equity

0.76

Net debt / FCF

Piotroski F-Score

Property, plant and equipment

$702.4M

Shareholders' equity

$518.1M

Tangible book value

$506.5M

Tangible book value per share

$14.63

Total assets

$1.5B

Total cash

$472.7M

Total debt

$867.7M

Total liabilities

$946.3M

WACC

11.44%

Metric	Value
Asset turnover	0.57
Current assets	$651.1M
Current liabilities	$98.3M
Current ratio	6.62
Inventory turnover	5.46
Net working capital	$103.8M
Quick ratio	5.87
Working capital	$552.8M
Working capital turnover	1.27

Metric

Value

Asset turnover

0.57

Current assets

$651.1M

Current liabilities

$98.3M

Current ratio

6.62

Inventory turnover

5.46

Net working capital

$103.8M

Quick ratio

5.87

Working capital

$552.8M

Working capital turnover

1.27

Metric	Value
Buyback yield / dilution	-1.53%
Dividend yield	0%
Shareholder yield	-1.53%

Metric

Value

Buyback yield / dilution

-1.53%

Dividend yield

Shareholder yield

-1.53%

Metric	Value
150-day SMA	$82.77
1D price change	-4.28%
1M price change	-20.79%
1M total return	-20.79%
1W price change	-9.62%
1W total return	-9.62%
1Y price change	-48.99%
1Y return CAGR	-49.02%
1Y total return	-48.99%
20-day SMA	$75.46
200-day SMA	$95.24
3M price change	-9.05%
3M total return	-9.05%
3Y price change	77.93%
3Y return CAGR	21.17%
3Y total return	77.93%
50-day SMA	$82.70
50-day SMA vs 200-day SMA	50under200
52-week high	$156.00
52-week high date	2025-12-02
52-week low	$60.11
52-week low date	2026-05-13
5Y price change	153.99%
5Y return CAGR	20.5%
5Y total return	153.99%
6M price change	-37.51%
6M total return	-37.51%
All-time high	$177.37
All-time high date	2024-08-23
All-time low	$10.00
All-time low date	2022-02-24
Average true range (ATR)	$3.64
Average volume	854.3K
Beta (1Y)	1.4
Beta (2Y)	1.07
Beta (5Y)	1.93
Change from 52-week high	-57.21%
Change from 52-week low	11.05%
Change from all-time high	-61.91%
Change from all-time low	575.6%
Change from open	-2.7%
Day's gap	-1.62%
Dollar volume	$63.2M
High price	$69.79
Low price	$66.71
Monthly RSI	42.54
Open price	$68.60
Position in 52-week range	1.14%
Premarket change	-0.19%
Premarket close	$69.73
Premarket price	$69.60
Premarket volume	1.7K
Previous close	$69.73
Price vs 150-day SMA	-18.37%
Price vs 20-day SMA	-10.47%
Price vs 200-day SMA	-29.06%
Price vs 50-day SMA	-18.31%
Relative volume	1.11
Return from IPO open	244.64%
Return from IPO price	336.19%
RSI	30.55
Sharpe ratio	-0.96
Sharpe ratio (3Y)	0.51
Sharpe ratio (5Y)	0.54
Sortino ratio	-1.15
Sortino ratio (3Y)	0.91
Sortino ratio (5Y)	1
Volume	946.2K
Weekly RSI	36.54
YTD price change	-44.46%
YTD total return	-44.46%

Metric

Value

150-day SMA

$82.77

1D price change

-4.28%

1M price change

-20.79%

1M total return

-20.79%

1W price change

-9.62%

1W total return

-9.62%

1Y price change

-48.99%

1Y return CAGR

-49.02%

1Y total return

-48.99%

20-day SMA

$75.46

200-day SMA

$95.24

3M price change

-9.05%

3M total return

-9.05%

3Y price change

77.93%

3Y return CAGR

21.17%

3Y total return

77.93%

50-day SMA

$82.70

50-day SMA vs 200-day SMA

50under200

52-week high

$156.00

52-week high date

2025-12-02

52-week low

$60.11

52-week low date

2026-05-13

5Y price change

153.99%

5Y return CAGR

20.5%

5Y total return

153.99%

6M price change

-37.51%

6M total return

-37.51%

All-time high

$177.37

All-time high date

2024-08-23

All-time low

$10.00

All-time low date

2022-02-24

Average true range (ATR)

$3.64

Average volume

854.3K

Beta (1Y)

1.4

Beta (2Y)

1.07

Beta (5Y)

1.93

Change from 52-week high

-57.21%

Change from 52-week low

11.05%

Change from all-time high

-61.91%

Change from all-time low

575.6%

Change from open

-2.7%

Day's gap

-1.62%

Dollar volume

$63.2M

High price

$69.79

Low price

$66.71

Monthly RSI

42.54

Open price

$68.60

Position in 52-week range

1.14%

Premarket change

-0.19%

Premarket close

$69.73

Premarket price

$69.60

Premarket volume

1.7K

Previous close

$69.73

Price vs 150-day SMA

-18.37%

Price vs 20-day SMA

-10.47%

Price vs 200-day SMA

-29.06%

Price vs 50-day SMA

-18.31%

Relative volume

1.11

Return from IPO open

244.64%

Return from IPO price

336.19%

RSI

30.55

Sharpe ratio

-0.96

Sharpe ratio (3Y)

0.51

Sharpe ratio (5Y)

0.54

Sortino ratio

-1.15

Sortino ratio (3Y)

0.91

Sortino ratio (5Y)

Volume

946.2K

Weekly RSI

36.54

YTD price change

-44.46%

YTD total return

-44.46%

Metric	Value
Float	33.6M
Float percentage	96.78%
Shares change (QoQ)	12.48%
Shares change (YoY)	1.53%
Shares held by insiders	3.19%
Shares held by institutions	102.62%
Shares outstanding	34.7M
Short % of float	25.48%
Short % of shares	24.66%
Short ratio	11.7 days

Metric

Value

Float

33.6M

Float percentage

96.78%

Shares change (QoQ)

12.48%

Shares change (YoY)

1.53%

Shares held by insiders

3.19%

Shares held by institutions

102.62%

Shares outstanding

34.7M

Short % of float

25.48%

Short % of shares

24.66%

Short ratio

11.7 days

TransMedics Group, Inc. (TMDX)

Price

Financial snapshot

Fair-value bridge

Latest news · TMDX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TMDX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TMDX

Frequently asked questions